About this trial
This project aims to evaluate Restory - a newly developed anonymous, iCBT prolonged exposure therapy program specifically tailored for victims of sexual abuse - using a pre-registered randomized controlled trial with waitlist control. The primary research question is whether Restory is more effective than a waitlist control in reducing PTSD symptom severity score, as measured by PCL-5.
Eligibility criteria
Qualifiers
18+ years
exposure to sexual violence where a minimum of 1 month has passed since the incident
self-reported total PCL-5 of minimum 30
current stable dose of psychotropic medication (for at least 4 weeks) or medication free
Disqualifiers
Ongoing trauma-related threat (e.g. living with a violent spouse)
severe psychiatric illness requiring immediate alternative treatment (such as high acute suicide risk or presence of psychotic episode, assessed during screening interview)
current participation in other trauma-focused CBT or Eye Movement Desensitization and Reprocessing therapy
current benzodiazepine treatment
Trial design
Treatments tested in this trial
- Restory